Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 1C
Devotta A et al. (2023)
|
Xla Wt + pax3 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.1.F, Fig. S3.A
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.1.F, Fig. S3.A
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig. 2.F,G
Wang H et al. (2021)
|
Xtr.fermt2tm-/- Huzha
NF15 (RT-PCR)
|
|
|
|
Fig.1.F, Fig. S3.A
Wang H et al. (2021)
|
Xtr Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.1.B-C
Perfetto M et al. (2021)
|
Xtr Wt + ddx3x MO
NF12.5 (in situ hybridization)
|
|
|
|
Fig. 4 F, Sup. Fig. 2 B
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 9 b-l
Shang N et al. (2020)
|
Xla.wt + dab2 MO
NF31
|
|
|
|
Fig. 4A col3, E
Schwenty-Lara J et al. (2020)
|
Xla Wt + kmt2d MO
NF 17-18
|
|
|
|
Fig. 4A col4, E
Schwenty-Lara J et al. (2020)
|
Xla Wt + kmt2d MO
NF 17-18
|
|
|